WO2025068978 - CELLULAR CATALYST MEMBER FOR REMEDIATING A DISINFECTANT
National phase entry is expected:
Publication Number
WO/2025/068978
Publication Date
03.04.2025
International Application No.
PCT/IB2024/059479
International Filing Date
27.09.2024
Title **
[English]
CELLULAR CATALYST MEMBER FOR REMEDIATING A DISINFECTANT
[French]
ÉLÉMENT CATALYSEUR CELLULAIRE POUR RESTAURER UN DÉSINFECTANT
Applicants **
SABAN VENTURES PTY LIMITED
Inventors
COGAR, Luke John George
SPARGO, Gavin Michael
WADHWANI, Rishi Haresh
Priority Data
63/585,690
27.09.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2955 | |
| EPO | Filing, Examination, Granting | 25280 | |
| Japan | Filing, Examination, Granting | 2993 | |
| South Korea | Filing, Examination, Granting | 3730 | |
| USA | Filing, Examination, Granting | 8940 |
Total:
43,898
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
A method includes directing a disinfectant flow across at least one portion of a medical device to clean the at least one portion of the medical and flowing the disinfectant through a cellular catalyst member to remediate the disinfectant. The cellular catalyst member includes pores that form flow paths for the disinfectant.[French]
La présente invention concerne un procédé qui consiste à diriger un écoulement de désinfectant à travers au moins une partie d'un dispositif médical pour nettoyer ladite ou lesdites parties du dispositif médical et à faire s'écouler le désinfectant à travers un élément catalytique cellulaire pour restaurer le désinfectant. L'élément catalytique cellulaire comprend des pores qui forment des trajets d'écoulement pour le désinfectant.